SCHEMBL6991396

SCHEMBL6991396

CCOC(=O)N1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 9/20 0.60
SLC6A15 Q9H2J7 8/20 0.48
LMNA P02545 2/20 0.48
FNTA P49354 2/20 0.48
FNTB P49356 2/20 0.48
USP2 O75604 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
CACNA1F O60840 1/20 0.48
NR1I2 O75469 1/20 0.48
GMNN O75496 1/20 0.48
ABCB11 O95342 1/20 0.48
TP53 P04637 1/20 0.48
CHRM2 P08172 1/20 0.48
ABCB1 P08183 1/20 0.48
CYP3A4 P08684 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7095204 0.86 HRH1 (0.62) HRH1SLC6A15LMNAFNTAFNTB
SCHEMBL6988373 0.85 HRH1 (0.61) HRH1SLC6A15LMNAFNTAFNTB
SCHEMBL6989409 0.85 HRH1 (0.61) HRH1SLC6A15LMNAFNTAFNTB
SCHEMBL9132213 0.85 SETD7 (0.43) HRH1LMNAFNTAFNTBMEN1
Alcaftadine SCHEMBL29378093 0.84 SETD7 (0.52) HRH1LMNAMEN1ABCB11TP53
Alcaftadine SCHEMBL1602418 0.84 SETD7 (0.52) HRH1LMNAMEN1ABCB11TP53
SCHEMBL9131650 0.81 HRH1 (0.46) HRH1SLC6A15LMNAFNTAFNTB
SCHEMBL6990388 0.81 HRH1 (0.46) HRH1SLC6A15LMNAFNTAFNTB
SCHEMBL15790929 0.80 SETD7 (0.38) HRH1LMNAFNTAFNTBMEN1
SCHEMBL9850494 0.79 HRH1 (0.76) HRH1SLC6A15LMNAFNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0588858-B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA NV (BE) 2003-09-17 EP disclosed
CN-1142360-A A method for preparing a medical composition conpaining imidazo[2,1-b][3] benzo azepine dericvants YUAN ANLING (CN) 1997-02-12 CN disclosed
EP-0588858-A1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA N.V. (BE) 1994-03-30 EP disclosed
WO-1992022551-A1 IMIDAZO[2,1-b][3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-23 WO disclosed
EP-0518435-A1 Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-16 EP disclosed